← Leaderboards
Susan Meitz
Albany Molecular Research, Inc.
$2,502,592
Attributed
$2,502,592
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2024–25$2M$1.5M$1M$500K$0
'24
'25
Funding mix
By agency
NIH$2,502,592 · 1
By mechanism
N01$2,502,592 · 1
Top collaborators
No co-investigators on record.
Most similar at Albany Molecular Research, Inc.
Same institution · by research overlap
- Keith Barnes$45,425,605
- John Reilly$2,579,604
- Melissa Allard$16,991,646
- Carrie Costello$1,542,434
- Matthew Surman$2,382,768
Others in their field
Other Rising Stars on “Validation”
- Cyrus Wadia · Activate Global, Inc.$24,000,000
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Kevin V Grimes · Stanford University$14,783,804
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Samuel W Teitelbaum · Arizona State University$13,377,213
Research focus
ValidationAnalytical MethodPreparationProgramsRegulationSmall MoleculeSupport NetworkUnited States Food And Drug AdministrationUnited States National Institutes Of HealthAccelerationClinical TrialsContractorContractsDocumentationDosage FormsDrug CandidateDrug DevelopmentDrug DistributionEarly Phase Clinical TrialEfficacy StudyFormulationGood Laboratory PracticeGood Manufacturing ProcessGrant